Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

87 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Connectomic Basis for Tremor Control in Stereotactic Radiosurgical Thalamotomy.
Middlebrooks EH, Popple RA, Greco E, Okromelidze L, Walker HC, Lakhani DA, Anderson AR, Thomas EM, Deshpande HD, McCullough BA, Stover NP, Sung VW, Nicholas AP, Standaert DG, Yacoubian T, Dean MN, Roper JA, Grewal SS, Holland MT, Bentley JN, Guthrie BL, Bredel M. Middlebrooks EH, et al. Among authors: nicholas ap. AJNR Am J Neuroradiol. 2023 Feb;44(2):157-164. doi: 10.3174/ajnr.A7778. Epub 2023 Jan 26. AJNR Am J Neuroradiol. 2023. PMID: 36702499 Free PMC article.
Connectomic-guided stereotactic radiosurgery thalamotomy for tremor: a patient-specific approach to enhance outcomes.
Middlebrooks EH, Patel V, Popple RA, Walker HC, Thomas EM, Brinkerhoff SA, Anderson AR, Deshpande HD, McCullough BA, Stover NP, Sung VW, Nicholas AP, Standaert DG, Yacoubian T, Dean MN, Roper JA, Grewal SS, Holland MT, Bentley JN, Guthrie BL, Bredel M. Middlebrooks EH, et al. Among authors: nicholas ap. J Neurosurg. 2025 Feb 14;143(1):53-62. doi: 10.3171/2024.10.JNS24753. Print 2025 Jul 1. J Neurosurg. 2025. PMID: 39951712
Trial of Prasinezumab in Early-Stage Parkinson's Disease.
Pagano G, Taylor KI, Anzures-Cabrera J, Marchesi M, Simuni T, Marek K, Postuma RB, Pavese N, Stocchi F, Azulay JP, Mollenhauer B, López-Manzanares L, Russell DS, Boyd JT, Nicholas AP, Luquin MR, Hauser RA, Gasser T, Poewe W, Ricci B, Boulay A, Vogt A, Boess FG, Dukart J, D'Urso G, Finch R, Zanigni S, Monnet A, Pross N, Hahn A, Svoboda H, Britschgi M, Lipsmeier F, Volkova-Volkmar E, Lindemann M, Dziadek S, Holiga Š, Rukina D, Kustermann T, Kerchner GA, Fontoura P, Umbricht D, Doody R, Nikolcheva T, Bonni A; PASADENA Investigators; Prasinezumab Study Group. Pagano G, et al. Among authors: nicholas ap. N Engl J Med. 2022 Aug 4;387(5):421-432. doi: 10.1056/NEJMoa2202867. N Engl J Med. 2022. PMID: 35921451 Clinical Trial.
Time-to-event analysis mitigates the impact of symptomatic therapy on therapeutic benefit in Parkinson's disease trials.
Pagano G, Trundell D, Simuni T, Pavese N, Marek K, Postuma RB, Shariati N, Monnet A, Moore E, Davies EW, Svoboda H, Pross N, Bonni A, Nikolcheva T; PASADENA Investigators; Prasinezumab Study Group. Pagano G, et al. NPJ Parkinsons Dis. 2025 Jul 1;11(1):193. doi: 10.1038/s41531-025-01041-9. NPJ Parkinsons Dis. 2025. PMID: 40593721 Free PMC article.
Exploratory digital outcome measures of motor sign progression in Parkinson's disease patients treated with prasinezumab.
Taylor KI, Lipsmeier F, Scelsi MA, Volkova-Volkmar E, Rukina D, Popp W, Lambrecht S, Anzures-Cabrera J, Summers D, Abt M, Monnet A, Kilchenmann T, Schjodt-Eriksen J, Essioux L, Kustermann T, Zago W, Svoboda H, Nikolcheva T, Postuma RB, Pagano G, Lindemann M; PASADENA Investigators; Prasinezumab Study Group. Taylor KI, et al. NPJ Digit Med. 2025 Jun 16;8(1):365. doi: 10.1038/s41746-025-01572-8. NPJ Digit Med. 2025. PMID: 40523921 Free PMC article.
Author Correction: Time-to-event analysis mitigates the impact of symptomatic therapy on therapeutic benefit in Parkinson's disease trials.
Pagano G, Trundell D, Simuni T, Pavese N, Marek K, Postuma RB, Shariati N, Monnet A, Moore E, Davies EW, Svoboda H, Pross N, Bonni A, Nikolcheva T; PASADENA Investigators; Prasinezumab Study Group. Pagano G, et al. NPJ Parkinsons Dis. 2025 Aug 13;11(1):241. doi: 10.1038/s41531-025-01103-y. NPJ Parkinsons Dis. 2025. PMID: 40804248 Free PMC article. No abstract available.
Myths and Methodologies: Standardisation in Human Physiology Research-Should We Control the Controllables?
Merrell LH, Perkin OJ, Bradshaw L, Collier-Bain HD, Collins AJ, Davies S, Eddy R, Hickman JA, Nicholas AP, Rees D, Spellanzon B, James LJ, McKay AKA, Smith HA, Turner JE, Koumanov F, Maher J, Thompson D, Gonzalez JT, Betts JA. Merrell LH, et al. Among authors: nicholas ap. Int J Sport Nutr Exerc Metab. 2024 May 19;34(4):242-250. doi: 10.1123/ijsnem.2024-0091. Print 2024 Jul 1. Int J Sport Nutr Exerc Metab. 2024. PMID: 38763509 Free article. Review.
Myths and Methodologies: Standardisation in human physiology research-should we control the controllables?
Merrell LH, Perkin OJ, Bradshaw L, Collier-Bain HD, Collins AJ, Davies S, Eddy R, Hickman JA, Nicholas AP, Rees D, Spellanzon B, James LJ, McKay AKA, Smith HA, Turner JE, Koumanov F, Maher J, Thompson D, Gonzalez JT, Betts JA. Merrell LH, et al. Among authors: nicholas ap. Exp Physiol. 2024 Jul;109(7):1099-1108. doi: 10.1113/EP091557. Epub 2024 May 19. Exp Physiol. 2024. PMID: 38763158 Free PMC article. Review.
The emerging postural instability phenotype in idiopathic Parkinson disease.
Skidmore FM, Monroe WS, Hurt CP, Nicholas AP, Gerstenecker A, Anthony T, Jololian L, Cutter G, Bashir A, Denny T, Standaert D, Disbrow EA. Skidmore FM, et al. Among authors: nicholas ap. NPJ Parkinsons Dis. 2022 Mar 18;8(1):28. doi: 10.1038/s41531-022-00287-x. NPJ Parkinsons Dis. 2022. PMID: 35304493 Free PMC article.
87 results